PRIA H2 Review - Q3 & Q4 Highlights

Nancy Bax • December 23, 2025

In this issue of PRIA Pages, we've combined all of our many activities throughout the third and fourth quarters of 2025 into one, and it's an impressive look back at all we've been up to!  LSI Europe, The MedTech Conference, & Medtech Strategist's Innovation Summit in San Diego were just some of the conferences that PRIA participated in over the past few months. We hosted two successful webinars -- one on the WISeR model, and what we knew early on; and one on the importance of a Patient Access Program, with clients who spoke from first-hand experience.  PRIA is committed to staying abreast of industry news, with our team attending MDMA's annual meeting, and sharing our expertise in partner webinars and on live in-person panels.  It has been a busy and exciting year, and we look forward to 2026!


Click to Read the PDF

PRIA Pages H2 2025

Click the Icon below to share this with your network

Regulatory Meets Reimbursement: What MedTech Innovators Need to Know About FDA Breakthrough & Beyond
June 19, 2026
Regulatory Meets Reimbursement: What MedTech Innovators Need to Know About FDA Breakthrough and Beyond
Stop Guessing What FDA Wants by Sam Murray
By Sam Murray June 4, 2026
Stop Guessing What FDA Wants
You Got Your 510(k). Now What?
By Suzy Engwall May 28, 2026
You Got Your 510(k). Now What?
Right Sizing Your Quality System by Sam Murray
By Sam Murray, Head of Regulatory & Quality May 21, 2026
Right Sizing Your Quality System
Cleared for takeoff: Insights from a Medtech First Officer
By Suzy Engwall May 19, 2026
Five Mistakes MedTech StartUps Make Before Their First VAC Meeting
Using Regulatory as a Strategy and Not a Milestone
By Sam Murray, PRIA May 14, 2026
Using Regulatory as a Strategy and Not a Milestone
Reading the Water: Navigating What Matters in Regulatory and Quality  - Sam Murray, PRIA
By Sam Murray, Head of Regulatory & Quality May 6, 2026
An informative article series from PRIA Healthcare's Head of Regulatory and Quality, Sam Murray
Medical device strategy CMS/FDA RAPID program
April 24, 2026
PRIA examines the impact of the RAPID program, accelerating Medicare access for Breakthrough Devices by aligning FDA approval & CMS coverage, earlier, on innovators.
MedTech Clinical Evidence Strategy
By PRIA Healthcare April 20, 2026
PRIA's experts on reimbursement and regulatory issues weigh in on CMS's proposed NTAP change, and what it may mean for MedTech innovations.
PRIA Healthcare welcomes Sam Murray as Head of Regulatory and Quality Services
March 10, 2026
PRIA Healthcare is thrilled to announce that Sam Murray has joined PRIA as our Head of Regulatory and Quality. Sam brings more than a decade of experience doing exactly that kind of high-stakes, high-impact regulatory work across medical devices, diagnostics, combination products, and software-enabled technologies.
PRIA a strategic and execution partner for reimbursement and market access
By Tonya Dowd, MPH, Executive Vice President, Reimbursement, Health Economics, Market Access and Corporate Development February 23, 2026
MedTech reimbursement and market access, core drivers of valuation, acquisition potential, and long-term viability, should be developed in sync with your regulatory strategy
PRIA is proud to support LSI in 2026
By Nancy Bax November 6, 2025
Continuing and Strengthening our Relationship with a Vital Industry Event